Assetmark Inc. Boosts Stock Position in Alnylam Pharmaceuticals, …

3 days ago · Assetmark Inc. grew its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 8.2% during the 3rd quarter, according to the company in …

CouponFollow Extension

2%
OFF

Assetmark Inc. Boosts Stock Position In Alnylam Pharmaceuticals, …

1 week from now

3 days ago · Assetmark Inc. grew its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 8.2% during the 3rd quarter, according to the company in …

etfdailynews.com

$273.91
OFF

Alnylam Pharmaceuticals' (ALNY) Buy Rating Reiterated At

1 week from now

Nov 4, 2024 · Shares of ALNY stock opened at $273.91 on Monday. Alnylam Pharmaceuticals has a fifty-two week low of $141.98 and a fifty-two week high of $304.39. ... Assetmark Inc. …

marketbeat.com

2%
OFF

Assetmark Inc. Raises Position In Alnylam Pharmaceuticals, Inc.

1 week from now

3 days ago · Assetmark Inc. boosted its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 8.2% in the 3rd quarter, according to its most recent disclosure with the …

americanbankingnews.com

8%
OFF

Alnylam Pharmaceuticals (ALNY) Is A Great Momentum Stock: …

1 week from now

Over the past quarter, shares of Alnylam Pharmaceuticals have risen 26.8%, and are up 80.82% in the last year. In comparison, the S&P 500 has only moved 5.5% and 40.28%, respectively. …

yahoo.com

0%
OFF

Baillie Gifford & Co. Has $1.34 Billion Stock Holdings In Alnylam ...

1 week from now

5 days ago · Baillie Gifford & Co. trimmed its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 19.0% in the third quarter, according to the company in its …

marketbeat.com

$322.83
OFF

Alnylam Pharmaceuticals Stock: A Deep Dive Into Analyst ... - Nasdaq

1 week from now

4 days ago · In the assessment of 12-month price targets, analysts unveil insights for Alnylam Pharmaceuticals, presenting an average target of $322.83, a high estimate of $400.00, and a …

nasdaq.com

40%
OFF

Alnylam's Stock Surges As Heart Drug Vies With A Pfizer Blockbuster

1 week from now

Jun 24, 2024 · Alnylam Pharmaceuticals Inc.'s stock (ALNY) jumped nearly 40% premarket on Monday after the company released results of a late-stage trial for a heart drug that analysts …

morningstar.com

40%
OFF

Alnylam Pharmaceuticals Inc - Morningstar

1 week from now

Jun 25, 2024 · Alnylam Pharmaceuticals Inc. ALNY: XNAS (USA) ... to the good news and have sent the stock up over 40%. ... safety profile should support broad use and could position …

morningstar.com

$205
OFF

Alnylam Cut To Underperform At Wolfe Research Amid Amvuttra …

1 week from now

4 days ago · Wolfe Research downgraded Alnylam to Underperform from Peer Perform with a $205 price target The firm cites expectations that the company will expand its approved …

businessinsider.com

65%
OFF

Alnylam Stock Soars 65%: Find Out What’s Behind The Gains

1 week from now

Sep 12, 2024 · Alnylam Pharmaceuticals released the final results of a study that has it on track for expanded use of a key product. Expanded use could lead revenue to double or triple within …

marketbeat.com

7%
OFF

Cwm LLC Has $1.86 Million Stock Holdings In Alnylam …

1 week from now

Oct 16, 2024 · Cwm LLC raised its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 93.7% in the third quarter, according to its most recent …

marketbeat.com

4%
OFF

Asset Management One Co. Ltd. Boosts Stock Position In Alnylam ...

1 week from now

Nov 6, 2024 · Asset Management One Co. Ltd. raised its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 3.4% in the third quarter, according …

marketbeat.com

5%
OFF

Silvant Capital Management LLC Has $4.45 Million Holdings In …

1 week from now

Nov 2, 2024 · Silvant Capital Management LLC grew its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 18.5% in the 3rd quarter, according to its most recent filing …

marketbeat.com

3%
OFF

Swedbank AB Boosts Stake In Alnylam Pharmaceuticals, Inc

1 week from now

Oct 18, 2024 · Swedbank AB lifted its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 160.3% during the third quarter, according to its most recent 13F filing with …

marketbeat.com

4%
OFF

Los Angeles Capital Management LLC Has $37.68 Million Stock …

1 week from now

6 days ago · Los Angeles Capital Management LLC boosted its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 11,433.4% during the 3rd quarter, …

marketbeat.com

FAQs about Assetmark Inc. Boosts Stock Position in Alnylam Pharmaceuticals, … Coupon?

Why did Alnylam (ALNY) stock rise 57?

Shares of Alnylam Pharmaceuticals Inc. soared 57.0% in premarket trading on Wednesday after the company said its investigational RNAi therapeutic for a type of heart failure met the primary endpoint in a Phase 3 clinical ... Seeking Clues to Alnylam (ALNY) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics ...

Who is Alnylam Pharma?

Begin your TipRanks Premium journey today. Alnylam Pharma (ALNY) Company Description: Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. ...

Why has Tazeen Ahmad rated Alnylam Pharma a buy?

Tazeen Ahmad has given his Buy rating due to a combination of factors influencing Alnylam Pharma’s performance and future potential. One key aspect is the company’s strong revenue figures for its products, particularly Amvuttra and Onpattro, which have met or exceeded expectations. ...

What is ALNY momentum investing?

In This Article: ALNY Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." ...

Is ALNY a good momentum pick?

Let's discuss some of the components of the Momentum Style Score for ALNY that show why this RNA interference drug developer shows promise as a solid momentum pick. A good momentum benchmark for a stock is to look at its short-term price activity, as this can reflect both current interest and if buyers or sellers currently have the upper hand. ...